Spinal cord injury treatment maker InVivo Therapeutics Corp. has successfully wrapped up preliminary primate studies and is now looking to secure funds to go prime time.

During the summer, InVivo completed a primate and rodent study that demonstrated InVivo’s polymer-based technologies to be 100 percent effective, said Frank Reynolds, CEO of the Cambridge-based company. Continue Reading »

IT’S been two minutes and I’ve already got a nasty sweat up.

The carpet looked easy enough, but even my slight frame caused the wheelchair to dig in as if it was on soft sand, washing away any speed and wasting precious arm strokes.

Add in a dodgy front wheel that kept deciding left (usually towards the stairs) was the best direction and after 10 minutes of dodging desks, lift doors and walls, I was ready for a break.

And this is at a workplace set up to be wheelchair-friendly. Continue Reading »